Partner Article
IDS strengthens European network
MEDICAL testing kit maker IDS has snapped up a Norwegian firm and entered a partnership with a Dutch organisation as it continues to grow its global presence.
The Tyneside firm said has bought MGP Diagnostics (MGPD) for an undisclosed fee and set up a research agreement with VitaK BV of Maastrict in the Netherlands.
MGPD is involved in products related to the determination of a biomarker that can highlight conditions with soft tissues such as the carotid arteries and heart valves linked to cardiovascular disease.
Meanwhile, VitaK will work with IDS to accelerate the proof of concept studies needed in the same medical field.
Dr Roger Duggan, CEO of Boldon-based IDS, said: “This acquisition provides IDS with an IP-protected entry into an adjacent, highly complementary area of potential clinical importance.”
This was posted in Bdaily's Members' News section by Ruth Mitchell .
Enjoy the read? Get Bdaily delivered.
Sign up to receive our popular morning National email for free.
Talent is an asset, not an operational resource
Taking advantage of the opportunities ahead
Accountability isn’t the enemy of empathy
Act now to avoid a last-minute tax scramble
How inner-city living can transform a city by the sea
Artificial intelligence's value is the time it gives back
Why we must break the magnetic pull of London
AI scepticism is healthy - inaction isn't
What does NPPF mean for planning gain and pricing?
What new NPPF rules mean for landowners
The hidden cost squeezing Britain's economy
Teesside deserves more than cashback devolution